Congress Park Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Congress Park Capital's LLY Position: Q3 2026 in Review
Congress Park Capital reduced its Eli Lilly (LLY) stake by 2.3% in Q3 2026, selling an estimated $97.9K and leaving 3,524 shares worth $4.08M. The position accounts for 1.07% of the portfolio, ranked #28.
Congress Park Capital first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $4.33M in Q2 2026. 3,287 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Congress Park Capital held 3,524 shares of Eli Lilly worth $4.08M as of Q3 2026.
- Congress Park Capital sold 83 Eli Lilly shares in Q3 2026, an estimated $97.9K.
- Eli Lilly made up 1.07% of Congress Park Capital's portfolio in Q3 2026, its #28 holding.
- Congress Park Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Congress Park Capital's Eli Lilly position peaked at $4.33M in Q2 2026.
- 3,287 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Congress Park Capital's 13F filing for Q3 2026, filed 13 Oct 2026.